Peter Hensen

Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis

Calcineurin Inhibitor Nephrotoxicity

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Pathogenesis and therapy of psoriasis

Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa

Defining pathways

Genome-wide studies of psoriasis susceptibility loci: a review

Delivery technologies for cancer immunotherapy

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017

Psoriasis: genetic associations and immune system changes

Interleukin-12, interleukin-23, and psoriasis: Current prospects

Bartter’s and Gitelman’s Syndromes: From Gene to Clinic

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Inflammatory Muscle Diseases

Inwardly Rectifying K+ (Kir) Channels inDrosophila

Psoriasis Pathogenesis and Treatment

An inwardly rectifying K⁺ channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain

PEGylation in anti-cancer therapy: An overview

Delayed K ⁺ clearance associated with aquaporin-4 mislocalization: Phenotypic defects in brains of α-syntrophin-null mice

Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease

Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?

Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs

ATP-sensitive potassium channel (K _ATP )–dependent regulation of cardiotropic viral infections

Comparison of pegylated interferon α‐2b plus psoralen PUVA versus standard interferon α‐2a plus PUVA in patients with cutaneous T‐cell lymphoma

Instrumente zur Behandlungsoptimierung

Association scan of the novel psoriasis susceptibility region on chromosome 19: evidence for both susceptible and protective loci

Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis

Prenatal and Postnatal Management of Hyperprostaglandin E Syndrome After Genetic Diagnosis From Amniocytes

Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?

A Hyperprostaglandin E Syndrome Mutation in Kir1.1 (Renal Outer Medullary Potassium) Channels Reveals a Crucial Residue for Channel Function in Kir1.3 Channels

Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas.